outcomes of patients with dlbcl who relapse early following r-ice chemoimmunotherapy
Published 1 year ago • 592 plays • Length 3:35Download video MP4
Download video MP3
Similar videos
-
1:50
outcomes of patients with dlbcl following asct and/or car-t
-
1:39
managing early & late relapse after first-line therapy for dlbcl
-
1:32
evaluating the role of autosct in patients with dlbcl who relapse after first-line therapy
-
1:19
real-world outcomes of liso-cel therapy in r/r dlbcl
-
6:35
high grade diffuse large b-cell lymphoma: carole's story
-
3:08
laddl covid 19 testing laboratory
-
2:07
relapsed/refractory diffuse large b-cell lymphoma
-
5:24
treatment strategies for patients with dlbcl who relapse after car-t therapy
-
2:50
outcomes of delaying car-t infusion after lymphodepleting chemotherapy in patients with lbcl
-
1:57
using ai to predict the outcomes of patients with r/r dlbcl treated with tisagenlecleucel
-
4:26
mrd assessment for surveillance post-treatment in dlbcl
-
1:38
using pet to predict failure to salvage therapy in patients with dlbcl
-
3:10
the potential for early identification of relapse in dlbcl using serial ctdna sampling
-
2:25
relapse in dlbcl - addressing the unmet need with brentuximab vedotin
-
1:28
novel ultra-sensitive mrd profiling tool predicts outcomes in dlbcl after frontline treatment
-
0:43
the development of a composite comorbidity index to predict car-t outcomes in patients with dlbcl
-
0:43
phase i study of rapcabtagene autoleucel in patients with r/r dlbcl
-
2:31
ctdna allows for the prediction of outcomes following liso-cel infusion in patients with lbcl
-
8:57
outcomes of sct in t-all and t-lbl
-
1:20
axi-cel in patients with r/r lbcl in complete metabolic response
-
3:04
applying molecular understanding of dlbcl to management strategies
-
1:16
predictors of long-term survival in patients with dlbcl/hgbcl following autosct